Seer, Inc. (California) (SEER)
1.98
-0.09
(-4.35%)
USD |
NASDAQ |
Feb 20, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
Seer EPS Diluted (Quarterly) : -0.3238 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cerus Corp. | -0.0001 |
| Nephros, Inc. | 0.0305 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.23M |
| Revenue (Quarterly) | 4.121M |
| Total Expenses (Quarterly) | 22.36M |
| Enterprise Value | -58.55M |
| Gross Profit Margin (Quarterly) | 51.20% |
| Profit Margin (Quarterly) | -442.5% |
| Earnings Yield | -68.78% |
| Normalized Earnings Yield | -68.78 |